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Abstract  Introduction:  COVID-19  pandemic,  declared  on  March  11,  2020,  constitute  an
extraordinary  health,  social  and  economic  global  challenge.  The  impact  on  people’s  mental
health  is  expected  to  be  high.  This  paper  sought  to  systematically  review  community-based
studies on  depression  conducted  during  the  COVID-19  and  estimate  the  pooled  prevalence
of  depression.  Method:  We  searched  for  cross-sectional,  community-based  studies  listed  on
PubMed  or  Web  of  Science  from  January  1,  2020  to  May  8,  2020  that  reported  prevalence  of
depression.  A  random  effect  model  was  used  to  estimate  the  pooled  proportion  of  depression.
Results:  A  total  of  12  studies  were  included  in  the  meta-analysis,  with  prevalence  rates  of
depression  ranging  from  7.45%  to  48.30%.  The  pooled  prevalence  of  depression  was  25%  (95%
CI:  18%  −  33%),  with  significant  heterogeneity  between  studies  (I2 =  99.60%,  p  <  .001).  Conclu-
sions: Compared  with  a  global  estimated  prevalence  of  depression  of  3.44%  in  2017,  our  pooled
prevalence  of  25%  appears  to  be  7  times  higher,  thus  suggesting  an  important  impact  of  the
COVID-19  outbreak  on  people’s  mental  health.  Addressing  mental  health  during  and  after  this
global  health  crisis  should  be  placed  into  the  international  and  national  public  health  agenda
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Resumen  Introducción:  La  pandemia  de  COVID-19,  declarada  el  11  de  marzo  de  2020,  repre-
senta  un  reto  global  extraordinario  a  nivel  sanitario,  social  y  económico.  Se  espera  un  impacto
alto  en  la  salud  mental  de  las  personas.  Este  artículo  tiene  como  objetivo  realizar  una  revisión
sistemática  de  estudios  transversales  basados  en  muestras  comunitarias  que  proporcionaban  la
prevalencia  de  depresión  durante  la  crisis  del  COVID-19.  Método:  Se  realizó  una  búsqueda  de
estudios  comunitarios  publicados  en  Pubmed  y  Web  of  Science  desde  el  1  de  enero  del  2020
al  8  de  mayo  del  2020  y  que  informaron  sobre  la  prevalencia  de  depresión.  Se  usó  un  mod-
elo  de  efectos  aleatorios  para  estimar  la  proporción  agrupada  de  depresión.  Resultados:  Un
total  de  12  estudios  fueron  incluidos  en  el  meta-análisis,  con  prevalencias  de  depresión  que
oscilaban  entre  7,45%  y  48,30%.  La  prevalencia  agrupada  de  depresión  fue  de  25%  (95%  CI:  18%-
33%),  con  heterogeneidad  significativa  entre  estudios  (I2 =  99,60%,  p  <  0,001).  Conclusiones:  En
comparación  con  una  estimación  global  de  depresión  en  2017  del  3,44%,  nuestra  prevalencia
agrupada  del  25%  es  7  veces  mayor,  sugiriendo  un  impacto  importante  del  brote  de  COVID-19  en
la  salud  mental  de  las  personas.  El  abordaje  de  la  salud  mental  durante  y  después  de  esta  crisis
global  sanitaria  debe  ser  parte  de  las  agendas  de  salud  pública  nacionales  e  internacionales
para mejorar  el  bienestar  de  los  ciudadanos.
©  2020  Asociación  Española  de  Psicoloǵıa  Conductual.  Publicado  por  Elsevier  España,  S.L.U.































































The  novel  coronavirus  disease  (COVID-19)  was  declared  a
andemic by  the  World  Health  Organization  (WHO)  on  March
1, 2020  (World  Health  Organization,  2020b).  Since  its  iden-
ification in  a  wet  market  in  Wuhan,  China,  in  December
019 (Lu  et  al.  2020),  to  this  date  (May  14th,  2020),  there
as been  a  total  of  4,248,389  confirmed  cases  worldwide.
mong them,  294,046  have  died  (World  Health  Organization,
020a). This  pandemic,  and  the  public  health  measures
mplemented to  slow  it,  have  profoundly  changed  people’s
ifestyle and  is  thought  to  be  a  threaten  for  physical  and
ental wellbeing.
The unpredictable  nature  of  the  disease,  the  loss  of
ontrol and  personal  freedoms,  the  conflicting  messages
rom authorities,  sudden  changes  in  plans  for  the  immedi-
te future,  or  concern  for  one’s  own  health  and  well-being
nd that  of  one’s  relatives  are  examples  of  sources  of
tress associated  with  these  outbreaks  and  pandemics
Huremović, 2019).  With  the  COVID-19  pandemic,  this  has
een followed  by  home  confinement  for  indefinite  peri-
ds and  substantial  and  growing  financial  losses.  A  recent
ystematic review  on  the  psychological  impact  of  previ-
us confinement  due  to  several  pandemic  such  as  Ebola,
1N1 influenza  pandemic,  Middle  East  respiratory  syndrome
nd equine  influenza  found  negative  psychological  effects
ncluding post-traumatic  stress  symptoms,  anger  and  confu-
ion (Brooks  et  al.,  2020).  According  to  the  authors,  factors
uch as  long  duration  of  quarantine,  fears  for  infection,  inad-
quate information,  stigma,  or  financial  loss  were  related  to
igher negative  psychological  impact.  These  major  stressors
an be  expected  to  lead  to  an  increased  risk  of  psy-
hopathology such  as  anxiety  or  depression  (Huremović,
019; Pfefferbaum  &  North,  2020).
To  date  there  is  not  systematic  review  or  meta-analysis
ssessing the  prevalence  of  depression  in  the  general  popu-Please  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
ation. Two  reviews  have  provided  data  on  psychopathology
elated to  COVID-19,  but  while  one  covers  epidemic  out-




ffers  only  one  study  (Wang,  Di,  et  al.  2020)  that  examines
epression in  the  general  population.  Given  the  increasing
umber of  papers  addressing  mental  health  and  COVID-19
ublished in  the  last  month  from  various  countries,  we  con-
ucted a  systematic  review  and  meta-analysis  of  available
tudies investigating  depression  in  the  general  population
uring the  COVID-19  outbreak  in  order  to  obtain  a  more
lobal perspective.
ethod
his  study  was  conducted  in  accordance  with  the  PRISMA
uidelines for  reporting  systematic  reviews  and  meta-
nalysis (Moher  et  al.,  2009;  Perestelo-Pérez,  2013).
ppendix A.
earch  strategy
wo  researchers  searched  for  cross-sectional  studies  report-
ng the  prevalence  of  depression  published  from  January  1,
020 to  May  8,  2020  using  MEDLINE,  via  PubMed,  and  Web
f Science.  The  Pubmed  and  Web  of  Science  search  strate-
ies are  shown  in  Appendix  B.  No  language  restriction  was
ade. References  from  selected  articles  were  inspected  to
etect additional  potential  studies.  We  then  performed  a
anual search  of  the  ‘‘grey  literature’’  (e.g.,  medRxiv)  to
etect other  potentially  eligible  investigations.  Inter-rater
eliability analysis  showed  high  levels  of  agreement  between
he reviews  (Cohen’s  kappa  ()  ranged  from  .88  to  .94).  Any
isagreement was  resolved  by  consensus  among  a  third  and
ourth reviewers.al.  Prevalence  of  depression  during  the  COVID-19  out-
ional  Journal  of  Clinical  and  Health  Psychology  (2020),
nclusion  and  exclusion  criteria
tudies  were  included  if:  (1)  reported  cross-sectional  data
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break;  (2)  they  were  focused  on  community-based  samples;
(3) they  described  the  methods  used  to  assess  or  diagnose
depression; (4)  the  full-text  was  available.  We  excluded
studies focusing  on  specific  samples  (e.g.,  medical  profes-
sionals, patients,  adolescents),  and  review  articles.
Data  extraction
A  pre-designed  data  extraction  form  was  used  to  extract
information on  the  following  variables:  country,  sample  size,
prevalent rates  of  depression,  proportion  of  women,  average
age, instruments  used  to  assess  depression,  response  rate,
and sampling  methods.
Methodological  quality  assessmentPlease  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
Articles  selected  for  retrieval  were  assessed  by  two  indepen-
dent reviewers  for  methodological  validity  before  they  were
included  in  the  review  using  the  Joanna  Briggs  Institute  (JBI)





Figure  1  Flowchart  of   PRESS
analysis  3
tudies  (Moola  et  al.,  2017).  Inter-rater  reliability  analy-
is showed  high  levels  of  agreement  between  the  reviews
intra-class correlation  coefficient  =  .85,  95%  CI  =  .51-.95).
ny disagreements  that  arose  between  the  reviewers  were
esolved through  discussions,  or  by  further  discussion  with  a
hird reviewer  (PGG).
tatistical  analysis
 generic  inverse  variance  method  with  a  random  effect
odel was  used  (DerSimonian  &  Laird,  1986).  Freeman  and
ukey’s double  arcsine  transformation  of  prevalence  to  sta-
ilize the  variance  was  applied  (Freeman  &  Tukey,  1950).
he Hedges  Q  statistic  was  reported  to  check  heterogeneity
cross studies,  with  statistical  significance  set  at  p  <  .10.  Fol-
owing the  recommendations  for  a  small  number  of  studies
Higgins &  Green,  2011),  the  I2 statistic  and  95%  confidenceal.  Prevalence  of  depression  during  the  COVID-19  out-
ional  Journal  of  Clinical  and  Health  Psychology  (2020),
nterval was  also  used  to  quantify  heterogeneity  (von  Hippel,
015). I2 values  between  25%-50%  are  considered  as  low,
0%-75% as  moderate,  and  75%  or  more  as  high  (Higgins  et
l., 2003).  Heterogeneity  of  effects  between  studies  occurs

























































































Ahmed  et  al.
(2020)
China Convenience  sampling  1,074  33.54  (11.13)  46.80%  (503)  NR  BDI-II  37.10%  6
Gao  et  al.  (2020)  China  Convenience  sampling  4,872  32.20  (10)  67.70%  (3,267)  83.30%  WHO-5  (China)  48.30%  7
Huang  &  Zhao
(2020)
China Convenience  sampling  7,236  35.30  (5.60)  54.60%  (3,952)  85.30%  CES-D  (China)  20.10%  7
Kazmi  et  al.  (2020)  India  Random  sampling  1,000  NR  62%  (620)  66.70%  DASS-21  38.90%  6
Lei  et  al.  (2020)  China  Convenience  sampling  1,593  32.30  (9.80)  61.30%  (976)  80.20%  SDS  14.70%  7
Mazza  et  al.  (2020)  Italy  Convenience  sampling  2,766  32.94  (13.2)  71.66%  (1,982)  98.40%  DASS-21  32.70%  7
Nguyen  et  al.
(2020)
Vietnam Convenience  sampling  3,947  44.40  (17)  55.70%  (2,197)  NR  PHQ-9  7.40%  6
Ni  et  al.  (2020)  China  (Wuhan)  Convenience  sampling  1,577  NR  60.80%  (959)  NR  PHQ-9  19.20%  6
Shevlin  et  al.
(2020)
United Kingdom  Quota  sampling  2,025  45.44  (15.90)  51.70%  (1,047)  NR  PHQ-9  22.10%  7
Sønderskov  et  al.
(2020)
Denmark NR  2,458  49.10  (NR)  51%  (1,254)  NR  WHO-5  25.40%  7
Wang,  Pan,  Wan,
Tan, Xu,  Ho
et al.  (2020)
China  Snowball  sampling  1,210  NR  67.30%  (814)  92.80%  DASS-21  30.30%  7
Wang,  Di,  et  al.
(2020)
China NR  600  34  (12)  55.50%  (333)  99.20%  SDS  17.20%  7
Note. * Quality score based on the Joanna Briggs Institute (JBI) standardized critical appraisal instrument for prevalence studies (Moola et al., 2017; see Appendix C). SD = standard deviation;
NR = not reported; BDI-II = Beck depression inventory-second edition; WHO-5 = World Health Organization-five well-being index; CES-D = Center for Epidemiologic Studies-Depression scale;
DASS-21 = Depression, Anxiety and Stress scales; PHQ-9 = Patient Health Questionnaire; SDS = Sheehan Disability Scale.
ARTICLE IN PRESS+ModelIJCHP-196; No. of Pages 11
Prevalence  of  depression  during  the  COVID-19  outbreak:  A  meta-analysis  5


























Figure  2  Forest  plot  for
when  differences  in  results  for  the  same  exposure-disease
association cannot  be  fully  explained  by  sampling  varia-
tion. Sources  of  heterogeneity  can  include  differences  in
study design  or  in  demographic  characteristics.  We  per-
formed meta-regression  and  subgroup  analyses  (Thompson
& Higgins,  2002)  to  explore  the  sources  of  heterogeneity
expected in  meta-analyses  of  observational  studies  (Egger
et al.,  1998).  We  conducted  a  sensitivity  analysis  to  deter-
mine the  influence  of  each  individual  study  on  the  overall
result by  omitting  studies  one  by  one.  Publication  bias  was
determined through  visual  inspection  of  a  funnel  plot  and
Egger (Egger  et  al.,  1997)  and  Begg  (Begg  &  Mazumdar,  1994)
tests (p  values  <.10  indicate  publication  bias).
Statistical  analyses  were  conducted  by  JS  and  run  with
the metaprop  package  (Nyaga  et  al.,  2014),  STATA  statistical
software (version  10.0;  College  Station,  TX,  USA).
Results
Figure  1  shows  the  flow  chart  of  the  literature  search  strat-
egy and  the  study  selection  process.  Initially,  105  potential
records were  identified,  of  which  85  were  retrieved  from
PubMed and  20  from  Web  of  Science.  After  removing  dupli-
cates, the  titles  of  the  remaining  94  articles  were  read
and 66  of  them  were  excluded  for  not  meeting  inclusion
criteria. Subsequently,  the  abstracts  of  the  remaining  28Please  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
articles were  read  and  8  articles  were  removed  for  not  being
cross-sectional studies,  3  for  not  analyzing  the  prevalence  of
depression and  one  for  not  being  a  community-based  study.




prevalence  of  depression.
atabases  and  reference  lists.  After  reading  these  18  articles
n full,  we  finally  included  12  in  our  systematic  review.
Table  1  summarizes  the  characteristics  of  the  included
tudies (Ahmed  et  al.,  2020;  Gao  et  al.,  2020;  Huang  &  Zhao,
020; Kazmi,  Hasan,  Talib,  &  Saxena,  2020;  Lei  et  al.,  2020;
azza et  al.,  2020;  Nguyen  et  al.,  2020;  Ni  et  al.,  2020;
ønderskov, Dinesen,  Santini,  &  Østergaard,  2020;  Shevlin
t al.,  2020,  Wang,  Pan,  Wan,  Tan,  Xu,  Ho  et  al.,  2020;  Wang,
i, et  al.  2020),  7  of  which  were  from  China,  1  from  Viet-
am, 1  from  India,  and  three  from  Europe  (Italy,  Denmark
nd the  United  Kingdom).  The  sample  size  ranged  from  600
o  7,236  participants,  and  the  mean  age  ranged  from  32.20
o 49.10  years  in  the  nine  studies  reporting  it.  All  stud-
es included  both  men  and  women,  and  the  percentage  of
omen ranged  from  46.80%  to  71.66%,  with  a  majority  of
omen in  most  of  them.  All  studies  were  conducted  using
nline questionnaires,  and,  of  those  who  reported  it,  all  but
ne  used  non-random  sampling  methods.  The  response  rate
as reported  by  7  studies  and  ranged  from  66.66%  to  99.17%.
ll studies  measured  depression  using  standardized  scales,
he most  common  being  the  Depression,  Anxiety  and  Stress
cale (DASS)  and  the  Patient  Health  Questionnaire  (PHQ).
he studies  reported  highly  diverse  values  of  depression
revalence, ranging  from  7.45%  to  48.30%.
The  risk  of  bias  scores  ranged  from  6  to  7  out  of  a  possible
otal of  9,  with  a mean  score  of  6.4  (Appendix  C).  The  most
ommon limitations  were:  (a)  recruitment  of  participantsal.  Prevalence  of  depression  during  the  COVID-19  out-
ional  Journal  of  Clinical  and  Health  Psychology  (2020),
ot appropriate  (11  studies)  or  sample  not  clearly  represen-
ative of  the  population  (10  studies),  and  (b)  response  rate
ot reported,  or  large  number  of  non-responders  (6  studies).


















































































































Figure  3  Funnel  plot  for  the  prevalence  of  depression.
The  estimated  overall  prevalence  of  depression  was  25%
95% CI:  18%  −  33%;  Figure  2),  with  significant  heterogeneity
etween studies  (I2 =  99.60%,  p  <  .001).
Our meta-regression  showed  that  prevalence  of  depres-
ion was  independent  of  the  percentage  of  women,  mean
ge at  baseline,  response  rate,  or  methodological  quality.
either study  location  nor  sampling  method  were  signifi-
ant moderators  according  to  subgroup  analysis  (data  not
hown). The  only  significant  finding  was  a  lower  prevalence
f depression  for  studies  using  the  SDS  (Self-Rating  Depres-
ion Scale)  (15%  [95%  CI:  14%-17%])  or  the  PHQ-9  (16%  [95%
I: 7%-27%])  compared  to  those  using  the  DASS-21  (34%  [95%
I: 30%-38%])  or  the  WHO-5  (World  Health  Organisation-
ive Well-being  index)  (40%  [95%  CI:  39%-41%])  (p  <  .001).
o comparison  with  BDI-II  (Beck  Depression  Inventory--II)  or
ES-D (Center  for  Epidemiological  Studies--depression)  was
erformed since  only  one  study  using  each  one  was  found.
Excluding  each  study  one-by-one  from  the  analysis  did
ot substantially  change  the  pooled  prevalence  of  depres-
ion, which  varied  between  23%  (95%  CI:  18%-30%),  with
ao et  al.  (2020)  excluded,  to  27%  (95%  CI:  21%-35%),
ith Nguyen  et  al.  (2020)  excluded.  This  indicates  that  no
ingle study  had  a  disproportional  impact  on  the  overall
revalence. Visual  inspection  of  the  funnel  plot  (Figure  3)
uggested no  presence  of  publication  bias  for  the  estima-
ion of  prevalence,  confirmed  by  non-significant  results  in
he Begg’s  (p  =  .304)  and  Egger’s  (p  =  .126)  tests.  Publication
ias may  not  be  a  problem  in  this  meta-analysis,  since  the
revalence rate  is  the  outcome  measure  and  there  are  no
ignificant levels  that  may  have  biased  publications.  The  rea-
ons for  non-publication  are  more  likely  small  studies  with
oor methods.
iscussion
he  present  meta-analysis  of  twelve  large  studies  suggests
hat the  pooled  prevalence  of  depression  in  the  general
opulation during  the  COVID-19  outbreak  is  25%  (95%  CI:
8%-33%). The  main  source  of  heterogeneity  in  the  preva-
ence rates  of  depression  among  the  studies  included  in  thisPlease  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
eta-analysis was  the  scale  used  for  its  analysis,  with  the
ighest prevalence  rates  in  studies  using  the  WHO-5  and
ASS-21 scales,  and  the  lowest  in  those  using  the  PHQ-9  and
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mply  the  presence  of  biases  such  as  social  desirability  bias
Ahmed et  al.,  2020),  or  have  less  efficacy  than  standardized
linical interviews,  so  that  ultimately  the  sensitivity  of  the
ifferent scales,  even  standardized,  differs  greatly  (Dunstan
t al.,  2017).
The latest  global  estimated  prevalence  of  depression
s from  2017  and  shows  a  proportion  of  3.44%  (ranging
etween 2  and  6%)  (Ritchie  &  Roser,  2018).  This  estima-
ion, based  on  the  Global  Burden  of  Disease  data,  includes
oth dysthymia  and  major  depressive  disorder  and  it  is  based
n studies  reporting  depression  prevalence  rates  based  on
edical, epidemiological  data,  surveys  and  meta-regression
odelling. Our  results  suggest  that  rates  of  depression  in
he general  population  might  be  7  times  higher  during  the
OVID-19 outbreak.  However,  cautious  is  needed  when  inter-
reting  these  results,  since  the  type  of  instruments  and
riteria used  to  ascertain  depression  might  widely  differ
s well  as  the  number  of  studies  and  countries  included  in
he estimates.  This  is  especially  true  for  meta-analyses  that
ombine data  from  studies  using  different  assessment  tools,
uch as  diagnostic  interviews  and  screening,  self-reported
ests. Levis  et  al.  (2019),  for  example,  found  that  preva-
ence estimates  of  depression  based  on  rating  tools  were
n average  14%  greater  than  estimates  based  on  diagnostic
nterviews. Previous  meta-analysis  reporting  point  preva-
ence rates  of  depression  from  epidemiological  studies  that
sed both  symptoms  scales  and  diagnostic  tools,  showed  a
lobal prevalence  of  depression  of  4.70%  (95%  CI  =  4.40--5%)
n 2010,  when  accounting  for  methodological  differences
Ferrari et  al.,  2013).  However,  a  meta-analysis  combining
ata from  30  countries  from  1994  and  2014  and  using  only
ommunity studies  using  self-reported  instruments  found  a
revalence of  17.30%  (95%  CI  =  15-19.90%)  (Lim  et  al.,  2018).
hus, and  despite  methodological  challenges  when  compar-
ng results  with  previous  data,  our  findings  still  suggest  that
he prevalence  rate  of  depression  during  confinement  and
OVID-19 seems  to  have  considerably  increased.
The  reported  rates  of  depression  in  the  general  popula-
ion during  previous  epidemic  outbreaks  (SARS  and  Ebola)
re between  3%  and  73.10%  (Chew  et  al,  2020),  and  most  of
hem are  lower  than  the  rate  of  depression  during  the  COVID-
9 outbreak  we  have  identified  here.  These  past  epidemics
ere contained  faster  and,  despite  a  higher  mortality  rate,
nfection rates  were  lower,  which  may  explain  the  preva-
ence of  lower  rates  of  depressive  symptoms  (Huremović,
019). Moreover,  Hawryluck  et  al.  described  that  the  length
nd uncertainty  of  the  lockdown  contributed  to  higher
evels of  depression  during  the  SARS  outbreak  in  Canada
Hawryluck et  al.,  2004).  Thus,  the  current  lockdown  mea-
ures imposed  all  around  the  world  could  also  explain  the
igher rates  of  depressive  symptoms  observed  during  the
OVID-19 outbreak.
Our  study  supports  the  need  for  integration  of  men-
al health  considerations  into  COVID-19  care,  including  the
onitoring of  psychological  symptoms  and  social  needs
ithin the  general  population  (Pfefferbaum  &  North,  2020).
epression is  a  normal  reaction  to  a  sudden  worsening
n living  circumstances,  involving  separation  and  uncer-al.  Prevalence  of  depression  during  the  COVID-19  out-
ional  Journal  of  Clinical  and  Health  Psychology  (2020),
ainty (Huremović, 2019).  When  people  are  exposed  to
ncontrollable events,  they  exhibit  helplessness  and  lack
f motivation,  with  depression  as  a  consequence  (Seligman,
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to  seek  help  either  for  physical  or  mental  symptoms  (Lei
et al.,  2020);  thus,  and  similar  to  anxiety  (Asmundson  &
Taylor, 2020),  depression  can  become  a  barrier  to  rational
medical and  mental  health  interventions  during  pandemics
(Wang, Pan,  Wan,  Tan,  Xu,  Ho  et  al.,  2020).  Mental  health  of
the general  population  should  be  placed  within  the  national
and international  public  health  agenda,  with  appropriate
psychological support  provided  by  governments  or  commu-
nity agencies  (Lei  et  al.,  2020).
The  papers  we  reviewed  report  associations  between
several variables  and  increased  rates  of  depression  in  the
general population.  Associations  with  some  variables,  such
as suspected  COVID  symptoms  (Nguyen  et  al.,  2020),  having
a contact  infected  by  COVID  (Mazza  et  al.,  2020;  Ni  et  al.,
2020), fatality  rates  of  COVID  reported  in  the  areas  where
respondents belong  to  (Ahmed  et  al.,  2020),  poorer  self-
rated health  status  (Gao  et  al.,  2020;  Lei  et  al.,  2020;  Wang,
Di, et  al.  2020),  and/or  history  of  chronic  illness  (Mazza
et al.,  2020;  Shevlin  et  al.,  2020;  Wang,  Di,  et  al.  2020)  are
expected. Additionally,  increased  rates  of  depression  were
consistently found  to  be  associated  with  non-health  related
variables, such  as  younger  ages  (Ahmed  et  al.,  2020;  Gao
et al.,  2020;  Huang  &  Zhao,  2020;  Shevlin  et  al.,  2020).  In
fact, some  studies  found  higher  rates  of  depression  specif-
ically among  students  (Lei  et  al.,  2020;  Wang,  Pan,  Wan,
Tan, Xu,  Ho  et  al.,  2020).  Young  population  could  be  more
vulnerable to  uncertainty  about  the  future  of  jobs,  careers
and economic  crisis  (Kazmi  et  al.,  2020)  and  they  are  also
more exposed  to  social  media.  Interestingly,  despite  the  fact
that a  regular  update  on  health  information  related  to  COVID
seems to  decrease  depression  (Nguyen  et  al.,  2020;  Wang,
Di, et  al.  2020),  it  is  also  suggested  that  the  exposure  to
social media  is  associated  with  depression  (Ni  et  al.,  2020)
and mixed  anxiety  and  depression  (Gao  et  al.,  2020).  Social
media can  generate  an  immediate  flooding  of  fear  during  the
rapid spread  of  a  disease,  independently  of  real  risk  (Ofri,
2009) and  fostered  by  popularity  which  is  quickly  reached  by
post with  inaccurate  information  (‘‘fake  news’’)  (Sommariva
et al.,  2018).  Socio-economic  factors  such  as  unemployment
(Kazmi et  al.,  2020;  Mazza  et  al.,  2020),  low  social  status
(Nguyen et  al.,  2020),  lack  of  social  support  (Ni  et  al.,  2020)
and economic  losses  (Lei  et  al.,  2020)  can  also  contribute  to
higher rates  of  depression.
Mazza  et  al.  (2020)  was  the  only  study  that  focused  on
the influence  of  personality  traits  in  depression  rates  during
COVID-19 outbreak,  reporting  higher  rates  of  depression  in
individuals that  scored  higher  in  negative  affect  and  detach-
ment. They  also  found  higher  vulnerability  for  individuals
with a  history  of  stressful  situations  (Mazza  et  al.,  2020).
The association  between  depression  and  anxiety  was  also
frequently observed  in  two  studies  (Gao  et  al.,  2020;  Wang,
Di, et  al.  2020).
Depression that  appears  under  these  circumstances  may
rarely require  pharmacological  treatment,  at  least  in  the
short term.  COVID-19  outbreak  and  lockdown  situation
constitutes an  extraordinary  circumstance  that  requires  sig-
nificant personal  and  social  adjustments.  Thus,  depression
linked to  this  specific  context  could  be  best  addressed  withPlease  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
supportive interventions,  such  as  reassurance  and  provision
of accurate  information,  and  by  empowering  individuals  to
make right  decisions  and  helping  them  to  establish  an  activ-







Huremović, 2019).  Moreover,  it  is  suggested  that  healthy
ehaviors during  the  quarantine,  such  as  having  more  physi-
al  activity  and  eating  healthier,  could  also  help  counteract
epression (Nguyen  et  al.,  2020).
To  our  knowledge,  this  is  the  first  systematic  review
f all  available  studies  of  depression  in  the  general  pop-
lation during  the  COVID-19  outbreak,  and  the  first  one
o implement  meta-analytic  procedures.  Meta-analysis  con-
ers greater  power  than  individual  studies  to  estimate  more
ccurate rates  of  depression,  by  considering  a  much  larger
opulation drawn  from  different  countries.
However,  limitations  should  be  considered  when  inter-
reting our  results.  First,  and  due  to  the  fact  that  studies
ere conducted  during  the  COVID-19  outbreak,  they  had
articular constraints.  For  example,  randomization  of  the
ample was  not  possible  in  some  cases,  and  data  had  to
e collected  via  online  surveys,  which  might  have  intro-
uced selection  biases  such  as  oversampling  younger  and
ore educated  people  (Wang,  Di,  et  al.  2020).  Second,  we
ound that  the  use  of  different  scales  to  assess  depression
as a  major  source  of  the  heterogeneity.  Third,  the  included
tudies were  all  cross-sectional,  thus  making  difficult  the
stablishment of  casual  associations  between  the  pandemic
nd depression.  Forth,  the  studies  did  not  consider  preexist-
ng psychiatric  conditions  that  might  be  related  to  higher  risk
f depression  (Shigemura  et  al.,  2020).  Fifth,  depression  was
ot assessed  at  different  stages  of  the  epidemic  and  duration
f quarantine  was  not  considered  into  account.  Only  Wang,
an, Wan,  Tan,  Xu,  McIntyre,  et  al.  2020  investigated  the
sychological impact  of  COVID-19  during  the  initial  outbreak
nd four  weeks  later,  during  the  epidemic’s  peak,  and  found
o significant  difference  in  depression  levels.  Finally,  our
eta-analysis focuses  on  studies  including  general  popula-
ion. The  impact  of  COVID-19  on  the  psychological  wellbeing
f vulnerable  groups,  such  as  health  workers,  outpatients  or
lderly people  is  expected  to  be  high.  Thus,  future  epidemi-
logical studies  conducted  within  these  subpopulations  as
ell as  systematic  reviews  pooling  the  evidence  are  specially
eeded to  adapt  public  health  interventions.
Taking  into  account  that  the  overall  global  prevalence
f depressive  disorders  is  estimated  to  be  around  3.44%,
ur results  seem  to  suggest  that  the  proportion  of  depres-
ion in  the  general  population  is  7  times  higher  during  the
OVID-19 outbreak.  This  implies  a  substantial  impact  of  the
urrent pandemic  situation  on  mental  health  that  should  be
argeted by  individual  and  population-level  strategies.  This
volving situation  requires  jointly  efforts  from  the  scientific
ommunity to  contribute  to  the  population  surveillance  dur-
ng quarantine  and  the  COVID-19  outbreak  and  to  investigate
he negative  impact  on  psychological  wellbeing  in  the  short
nd long  term.  In  this  respect,  new  studies  are  continuing  to
e published  and  the  number  of  them  is  expected  to  increase
n the  coming  months  (e.g.,  Brailovskaia  &  Margraf,  2021).
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Appendix B. Web search strategies
MEDLINE  via  PubMed:  (covid  or  covid-19  OR  coronavirus  OR  ‘‘corona  virus’’  OR  SARSCoV-2  OR  ‘‘Coronavirus’’[Mesh]  OR
‘‘severe acute  respiratory  syndrome  coronavirus  2’’[Supplementary  Concept]  OR  ‘‘COVID-19’’[Supplementary  Concept]  OR
‘‘Coronavirus Infections/epidemiology’’[Mesh]  OR  ‘‘Coronavirus  Infections/prevention  and  control’’[Mesh]  OR
‘‘Coronavirus Infections/psychology’’[Mesh]  OR  ‘‘Coronavirus  Infections/statistics  and  numerical  data’’[Mesh])  AND
(depression OR  depressive  OR  ‘‘Depression’’[Mesh]  OR  ‘‘Depressive  Disorder’’[Mesh]  OR  hypothimia)
Web  of  Science:  ALL  =  (covid  or  covid-19  OR  coronavirus  OR  ‘‘corona  virus’’  OR  SARSCoV-2  OR  ‘‘severe  acute  respiratory
syndrome coronavirus  2’’)  AND  ALL  =  (depression  OR  depressive)
Appendix C. Risk of bias assessment*
Quality  scores  (from  1  to  9)
Study 1  2  3  4  5  6  7  8  9  TOTAL
Ahmed  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  U  6
Gao  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  Y  7Please  cite  this  article  in  press  as:  Bueno-Notivol,  J.,  et  
break:  A  meta-analysis  of  community-based  studies.  Internat
https://doi.org/10.1016/j.ijchp.2020.07.007
Huang  &  Zhao  (2020)  N  N  Y  Y  Y
Kazmi  et  al.  (2020)  N  Y  Y  N  Y
Lei  et  al.  (2020)  N  N  Y  Y  Y
Mazza  et  al.  (2020)  N  N  Y  Y  Yal.  Prevalence  of  depression  during  the  COVID-19  out-
ional  Journal  of  Clinical  and  Health  Psychology  (2020),
 Y  Y  Y  Y  7
 Y  Y  Y  N  6
 Y  Y  Y  Y  7
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guyen  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  U  6
i  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  U  6
hevlin  et  al.  (2020)  Y  N  Y  Y  Y  Y  Y  Y  U  7
onderskov  et  al.  (2020)  Y  N  Y  Y  Y  Y  Y  Y  U  7
ang,  Pan,  Wan,  Tan,  Xu,  Ho  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  Y  7
ang,  Di,  et  al.  (2020)  N  N  Y  Y  Y  Y  Y  Y  Y  7
Note:  *  Quality  score  based  on  the  Joanna  Briggs  Institute  (JBI)  standardized  critical  appraisal  instrument  for  prevalence
tudies  (Moola  et  al.,  2017).  N:  No;  U:  Unclear;  Y:  Yes;  1:  Was  the  sample  frame  appropriate  to  address  the  target  population?;
:  Were  study  participants  recruited  in  an  appropriate  way?;  3:  Was  the  sample  size  adequate?;  4:  Were  the  study  subjects
nd  setting  described  in  detail?;  5:  Was  data  analysis  conducted  with  sufficient  coverage  of  the  identified  sample?;  6:  Were
alid  methods  used  for  the  identification  of  the  condition?;  7:  Was  the  condition  measured  in  a  standard,  reliable  way  for
ll  participants?;  8:  Was  there  appropriate  statistical  analysis?;  9:  Was  the  response  rate  adequate,  and  if  not,  was  the  low
esponse  rate  managed  appropriately?
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